Vanguard Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$301M Buy
6,048,496
+3,746
+0.1% +$182K ﹤0.01% 1336
2025
Q3
$289M Sell
6,044,750
-160,506
-3% -$6.46M ﹤0.01% 1346
2025
Q2
$196M Buy
6,205,256
+41,364
+0.7% +$1.33M ﹤0.01% 1507
2025
Q1
$202M Buy
6,163,892
+13,133
+0.2% +$465K ﹤0.01% 1483
2024
Q4
$222M Buy
6,150,759
+22,852
+0.4% +$805K ﹤0.01% 1495
2024
Q3
$191M Sell
6,127,907
-9,634
-0.2% -$301K ﹤0.01% 1567
2024
Q2
$164M Sell
6,137,541
-69,273
-1% -$2.01M ﹤0.01% 1596
2024
Q1
$212M Sell
6,206,814
-7,917
-0.1% -$236K ﹤0.01% 1482
2023
Q4
$180M Buy
6,214,731
+142,551
+2% +$3.78M ﹤0.01% 1569
2023
Q3
$167M Buy
6,072,180
+28,711
+0.5% +$874K ﹤0.01% 1527
2023
Q2
$182M Buy
6,043,469
+162,404
+3% +$5.68M ﹤0.01% 1512
2023
Q1
$213M Buy
5,881,065
+91,105
+2% +$3.5M 0.01% 1416
2022
Q4
$207M Buy
5,789,960
+109,718
+2% +$3.81M 0.01% 1412
2022
Q3
$192M Buy
5,680,242
+59,794
+1% +$1.95M 0.01% 1411
2022
Q2
$163M Buy
5,620,448
+81,628
+1% +$2.34M ﹤0.01% 1555
2022
Q1
$179M Buy
5,538,820
+25,671
+0.5% +$787K ﹤0.01% 1618
2021
Q4
$161M Buy
5,513,149
+35,406
+0.6% +$1.07M ﹤0.01% 1725
2021
Q3
$146M Sell
5,477,743
-6,681
-0.1% -$179K ﹤0.01% 1775
2021
Q2
$169M Buy
5,484,424
+29,869
+0.5% +$916K ﹤0.01% 1724
2021
Q1
$143M Buy
5,454,555
+156,477
+3% +$4.38M ﹤0.01% 1765
2020
Q4
$133M Buy
5,298,078
+88,338
+2% +$1.9M ﹤0.01% 1686
2020
Q3
$109M Sell
5,209,740
-212,278
-4% -$4.82M ﹤0.01% 1648
2020
Q2
$129M Sell
5,422,018
-41,461
-0.8% -$916K ﹤0.01% 1545
2020
Q1
$98.3M Buy
5,463,479
+157,590
+3% +$3.31M ﹤0.01% 1537
2019
Q4
$126M Sell
5,305,889
-76,826
-1% -$1.87M ﹤0.01% 1647
2019
Q3
$148M Buy
5,382,715
+37,498
+0.7% +$1.11M 0.01% 1513
2019
Q2
$177M Buy
5,345,217
+49,676
+0.9% +$1.7M 0.01% 1433
2019
Q1
$186M Buy
5,295,541
+57,479
+1% +$2.14M 0.01% 1392
2018
Q4
$174M Buy
5,238,062
+121,584
+2% +$5.23M 0.01% 1327
2018
Q3
$258M Buy
5,116,478
+160,765
+3% +$7.94M 0.01% 1216
2018
Q2
$297M Buy
4,955,713
+170,631
+4% +$8.84M 0.01% 1083
2018
Q1
$219M Buy
4,785,082
+202,986
+4% +$8.47M 0.01% 1225
2017
Q4
$183M Buy
4,582,096
+93,032
+2% +$3.68M 0.01% 1363
2017
Q3
$180M Buy
4,489,064
+988,529
+28% +$42.8M 0.01% 1348
2017
Q2
$151M Buy
3,500,535
+984,200
+39% +$35M 0.01% 1423
2017
Q1
$78.8M Buy
2,516,335
+156,094
+7% +$4.18M ﹤0.01% 1782
2016
Q4
$59.6M Buy
2,360,241
+157,698
+7% +$3.52M ﹤0.01% 1881
2016
Q3
$54.5M Buy
2,202,543
+246,067
+13% +$5.57M ﹤0.01% 1889
2016
Q2
$39.9M Buy
1,956,476
+177,648
+10% +$3.15M ﹤0.01% 2006
2016
Q1
$27.1M Buy
1,778,828
+58,662
+3% +$765K ﹤0.01% 2158
2015
Q4
$23.1M Buy
1,720,166
+293,470
+21% +$4.54M ﹤0.01% 2246
2015
Q3
$20M Buy
1,426,696
+120,967
+9% +$2.25M ﹤0.01% 2291
2015
Q2
$22.2M Buy
1,305,729
+420,100
+47% +$5.98M ﹤0.01% 2308
2015
Q1
$10.7M Buy
885,629
+64,120
+8% +$606K ﹤0.01% 2619
2014
Q4
$6.82M Buy
821,509
+48,589
+6% +$408K ﹤0.01% 2727
2014
Q3
$6.72M Buy
772,920
+115,085
+17% +$1.04M ﹤0.01% 2686
2014
Q2
$7.2M Buy
657,835
+129,274
+24% +$1.15M ﹤0.01% 2667
2014
Q1
$4.72M Buy
528,561
+123,904
+31% +$1.14M ﹤0.01% 2859
2013
Q4
$3.05M Buy
404,657
+48,465
+14% +$339K ﹤0.01% 3024
2013
Q3
$2.61M Buy
356,192
+3,309
+0.9% +$22.2K ﹤0.01% 3033
2013
Q2
$2.27M Buy
+352,883
New +$2.08M ﹤0.01% 3019

Other funds holding SUPN